DK1173764T3 - Fremgangsmåde til identifikation af et individ med risiko for irreversible neuroskader, omfattende trinnene kvantitativ bestemmelse af koncentrationen af pepsinogen I (PGI) og vitamin B12 - Google Patents

Fremgangsmåde til identifikation af et individ med risiko for irreversible neuroskader, omfattende trinnene kvantitativ bestemmelse af koncentrationen af pepsinogen I (PGI) og vitamin B12

Info

Publication number
DK1173764T3
DK1173764T3 DK00922683T DK00922683T DK1173764T3 DK 1173764 T3 DK1173764 T3 DK 1173764T3 DK 00922683 T DK00922683 T DK 00922683T DK 00922683 T DK00922683 T DK 00922683T DK 1173764 T3 DK1173764 T3 DK 1173764T3
Authority
DK
Denmark
Prior art keywords
individual
concentration
pepsinogen
pgi
analyte
Prior art date
Application number
DK00922683T
Other languages
Danish (da)
English (en)
Inventor
Pentti Sipponen
Matti Haerkoenen
Osmo Suovaniemi
Erik Forsblom
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Application granted granted Critical
Publication of DK1173764T3 publication Critical patent/DK1173764T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Electrotherapy Devices (AREA)
DK00922683T 1999-04-30 2000-04-28 Fremgangsmåde til identifikation af et individ med risiko for irreversible neuroskader, omfattende trinnene kvantitativ bestemmelse af koncentrationen af pepsinogen I (PGI) og vitamin B12 DK1173764T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI990991A FI990991L (fi) 1999-04-30 1999-04-30 Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi

Publications (1)

Publication Number Publication Date
DK1173764T3 true DK1173764T3 (da) 2006-05-08

Family

ID=8554566

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00922683T DK1173764T3 (da) 1999-04-30 2000-04-28 Fremgangsmåde til identifikation af et individ med risiko for irreversible neuroskader, omfattende trinnene kvantitativ bestemmelse af koncentrationen af pepsinogen I (PGI) og vitamin B12

Country Status (12)

Country Link
EP (1) EP1173764B1 (enExample)
JP (1) JP2002543430A (enExample)
CN (1) CN1353816A (enExample)
AT (1) ATE319088T1 (enExample)
AU (1) AU4299700A (enExample)
DE (1) DE60026285T2 (enExample)
DK (1) DK1173764T3 (enExample)
ES (1) ES2258453T3 (enExample)
FI (1) FI990991L (enExample)
PT (1) PT1173764E (enExample)
RU (1) RU2224258C2 (enExample)
WO (1) WO2000067029A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20010019L (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
FI20065542A0 (fi) * 2006-09-01 2006-09-01 Biohit Oyj Menetelmä ja näytteenottopakkaus vatsan limakalvon tilan arvioimiseksi
RU2413940C2 (ru) * 2009-02-02 2011-03-10 Государственное образовательное учреждение высшего профессионального образования Воронежская государственная технологическая академия Способ определения витамина b12 в водных растворах

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi

Also Published As

Publication number Publication date
JP2002543430A (ja) 2002-12-17
ATE319088T1 (de) 2006-03-15
FI990991A7 (fi) 2000-10-31
PT1173764E (pt) 2006-06-30
DE60026285T2 (de) 2006-11-09
CN1353816A (zh) 2002-06-12
WO2000067029A1 (en) 2000-11-09
DE60026285D1 (de) 2006-04-27
AU4299700A (en) 2000-11-17
FI990991A0 (fi) 1999-04-30
EP1173764A1 (en) 2002-01-23
RU2224258C2 (ru) 2004-02-20
ES2258453T3 (es) 2006-09-01
FI990991L (fi) 2000-10-31
EP1173764B1 (en) 2006-03-01

Similar Documents

Publication Publication Date Title
DK0988534T3 (da) Elektroniske fremgangsmåder og apparat til detektering af analytter
ATE416376T1 (de) Analysegeräte, biosensoren und verfahren
BRPI0519119A2 (pt) sistema colorimÉtrico e mÉtodo para detectar um analito
ATE378404T1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
DK1098658T3 (da) Manipulerede proteiner til detektering af analytter
WO2003056314A3 (de) Analysensystem zur bestimmung einer analytkonzentration unter berücksichtigung von proben- und analytunabhängigen lichtintensitätsänderungen
DK2126586T3 (da) Direkte bestemmelse af vitamin D i serum eller plasma
DK0820522T3 (da) Assays og indretninger til detektering af ekstrahepatisk galdeatresi
DK1352238T3 (da) Fremgangsmåde til påvisning af D-vitaminmetabolitter
DK1540010T3 (da) Anvendelse af biomarkører til påvisning af ovariecancer
MX336070B (es) Eventos de alfalfa tolerantes a glifosato y metodos para su deteccion.
DK1604203T3 (da) Fremgangsmåde til direkte bestemmelse af individuelle methotrexatmeta-bolitter
DE60325482D1 (de) Verfahren zur charakterisierung von biomolekülen mittels resultat-gesteuerter strategie
DK1371984T3 (da) Chromatografisk assay-anordning og fremgangsmåde til detektion af tilstedeværelsen af en analyt i en helblodpröve
WO2003036256A3 (en) Method and apparatus for increasing the dynamic range and accuracy of binding assays
CY1107490T1 (el) Μεθοδος για την ταυτοποιηση δειγματος σε θηλαστικα καθως και κιτ για την εκτελεση αυτης της μεθοδου
FI990992A0 (fi) Menetelmä peptisen haavan riskin määrittämiseksi
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE347105T1 (de) Verfahren, assay und kit zur quantifizierung von hiv-proteasehemmer
ATE525462T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
DK1173764T3 (da) Fremgangsmåde til identifikation af et individ med risiko for irreversible neuroskader, omfattende trinnene kvantitativ bestemmelse af koncentrationen af pepsinogen I (PGI) og vitamin B12
DK1400589T3 (da) Fremgangsmåde til påvisning af prokaryotisk DNA
DK1104547T3 (da) In vitro-fremgangsmåde til påvisning og diagnosticering af akutte koronarsyndromer
DK1386160T3 (da) Fremgangsmåde til påvisning af blodcelle-antigener og antistoffer rettet mod disse
DK1281083T3 (da) Fremgangsmåde til detektering af inflammation og inflammatoriske tilstande